market access Archives

Posted November 21, 2022

Copay accumulator programs have only one purpose; increase profits for payers. Patients don’t gain an advantage, nor do manufacturers. On...

Posted October 20, 2022

The 340B Program remains controversial. Hospitals and other Covered Entities (providers qualified to buy drugs at 340B prices) that benefit...

Posted September 15, 2022

The Inflation Reduction Act (IRA) passed on August 16th, 2022 brings big changes for the pharmaceutical industry. On August 31st...

Posted August 26, 2022

[DISCLAIMER: This isn’t a legal analysis. We’ve simplified provisions in the law where we could while still describing the intent...

Posted August 8, 2022

New price transparency rules set by the government are an opportunity to save money. Not for hospitals, not for payers,...

Posted July 20, 2022

Pharmacy Benefit Managers (PBMs) have received a lot of negative publicity lately. Here is some more: A new whistleblower lawsuit...

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway...

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway...

In this advanced program, learn about the growing competition between payers and providers as they seek to control the gateway...

Tag: market access